by Stacey Johnson | Feb 24, 2017
This week, BrainStorm Cell Therapeutics issued a news release announcing its intent to seek early regulatory approval to distribute its Amyotrophic Lateral Sclerosis (ALS) product to patients in Canada. This news was eagerly received by patient groups in Canada and...
by Stacey Johnson | Feb 17, 2017
Research2Reality will soon be celebrating its 2nd anniversary. I first wrote about it when it launched and was excited by its mission to highlight the work of scientists across Canada, from a variety of disciplines, and make their research interesting and...
by Stacey Johnson | Feb 10, 2017
There is a trend in the regenerative medicine field to include gene therapies when describing the work being performed by academics and industry, as in “cell and gene therapies.” The wider definition better reflects how the industry is evolving and acknowledges the...
by Stacey Johnson | Feb 3, 2017
The clock is ticking. Valentine’s Day is less than two weeks away. If you are flying solo this Valentine’s Day, I give you permission to stop reading here. (But it may be worth your while to stick around a little longer; remember the trend of single women buying...
by Stacey Johnson | Jan 27, 2017
Epidermolysis bullosa (EB) is a rare, and exceedingly painful, skin condition that I’ve written about here and here. Children with EB are sometimes referred to as “butterfly children” because their skin is said to be as fragile as a butterfly’s wings. The severity of...
by Stacey Johnson | Jan 20, 2017
A special thing happened this week at Phacilitate’s Cell and Gene Therapy World: W.O.M.E.N. in Advanced Therapies launched. The virtual group is the result of conversations begun more than a year ago with like-minded individuals who want to give women the tools they...
Comments